Zenas BioPharma, Inc. Income Statement

Income Statement Dec2023 Dec2024
Revenue & cost
Revenue 50.00M5.00M
Gross Profit 50.00M5.00M
Operating items
Research & Development 60.03M139.14M
Selling, General & Administrative 17.11M29.75M
Other Operating Expenses 10.00M
Operating Expenses 87.15M168.89M
Operating Income -37.15M-163.89M
EBIT -37.15M-163.89M
Non-operating items
Other Non Operating Income 0.62M8.18M
Non Operating Income 0.62M8.18M
Net income details
EBT -36.82M-160.92M
Tax Provisions 0.30M0.43M
Profit After Tax -37.12M-157.00M
Income from Continuing Operations -37.12M-161.35M
Consolidated Net Income -37.12M-161.35M
Income towards Parent Company -37.12M-161.35M
Net Income towards Common Stockholders -37.12M-161.35M
Additional items
EPS (Basic) -0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M
Shares Outstanding (Weighted Average) 26.56M41.79M
Shares Outstanding (Diluted Average) 1.53M13.20M
EBITDA -37.05M-156.83M